Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Merck shares trade at a significant discount to peers. The company faces challenges, but there are reasons to be bullish.

Dublin, Jan. 15, 2025 (GLOBE NEWSWIRE) -- The "Dog Vaccines Market Size, Share & Trends Analysis Report By Vaccine Type, By Disease Type, By Route Of Administration, By Duration Of Immunity ...

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top ...

Dublin, Jan. 15, 2025 (GLOBE NEWSWIRE) -- The "Dog Vaccines Market Size, Share & Trends Analysis Report By Vaccine Type, By Disease Type, By Route Of Administration, By Duration Of Immunity, By ...

When most people think about vaccines, they typically think about humans, however, vaccines also provide important ...

Merck has announced that its GARDASIL vaccine has received expanded approval for males in China, the first such indication in the country. New Jersey-based Merck, which does business outside of the ...

In October, Merck took up an option on the personalised RNA-based cancer vaccine with an upfront payment of $250 million as part of a collaboration first agreed in 2016 and expanded in 2018.

The most immediate impact will be on pet owners. Unvaccinated pets face a higher risk of illness and death from preventable diseases; although vaccines are not completely effective, and in some cases ...

Bauchi government has targeted about 540 dogs for rabies vaccine to prevent dogs in the state from contracting the zoonotic viral disease affecting the central nervous system of unvaccinated dogs.

Hundreds of Philadelphia’s pets and their owners streamed through the medical rooms of Ryan Veterinary Hospital on Monday, ...

Shares in Moderna were ticking upwards today after Merck & Co took up an option on a personalised RNA-based cancer vaccine with a payment of $250 million. It is the first time that Merck has ...